{
  "ptid_time": "019_S_4680_2012-04-24",
  "img_path": "/data/qiuhui/data/adni/images/019_S_4680/2012-04-24/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 17,419 mm³, 22.0% below the reference mean. With a Z-score of -0.55 (29.1th percentile), this represents normal volume ; hippocampal volume measures 6,436 mm³, 16.2% below the reference mean. With a Z-score of -1.82 (3.4th percentile), this represents moderate atrophy; whole brain volume measures 874,593 mm³, 15.0% below the reference mean. With a Z-score of -1.87 (3.1th percentile), this represents moderate atrophy; entorhinal cortex volume measures 4,178 mm³, 7.3% above the reference mean. With a Z-score of 0.57 (71.5th percentile), this represents normal volume ; fusiform gyrus volume measures 14,109 mm³, 22.5% below the reference mean. With a Z-score of -2.54 (0.6th percentile), this represents significant atrophy; middle temporal gyrus volume measures 15,867 mm³, 22.7% below the reference mean. With a Z-score of -2.02 (2.2th percentile), this represents significant atrophy. ",
  "text_data": "Age is 63.4 years. Gender is Female. Education: 19 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Hematopoietic-Lymphatic; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 29.0. MoCA: 24.0. Logical Memory: 9.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.38 SUVR (significant elevated); Amyloid beta: 487.90 pg/mL (mild reduced); Total tau: 246.20 pg/mL (normal ); Phosphorylated tau: 24.13 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the fusiform gyrus and middle temporal gyrus, along with moderate atrophy in the hippocampus and whole brain, which are key regions affected in Alzheimer's disease. Despite a normal MMSE (29), the MoCA (24) suggests mild cognitive impairment, and the presence of two APOE4 alleles along with elevated AV45 (amyloid PET) and mildly reduced Aβ supports an Alzheimer's biomarker profile.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **High**  \n\n*(Note: The diagnosis is MCI rather than dementia because cognitive testing does not yet show significant functional impairment, but the biomarker and atrophy patterns strongly suggest early Alzheimer's pathology.)*",
  "timestamp": "2025-07-26T01:07:32.867512"
}